Tumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. Disclaimer: AAAS and EurekAlert! are not ...
This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.
New research findings from Paula Bos, Ph.D., identified a type of immune cells that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces ...
Outcomes with COVID-19 in patients with hematopoietic stem cell transplant and cellular therapy: A systemic review and meta-analysis. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting ...
Processa Pharmaceuticals, Inc., a clinical-stage company specializing in next-generation cancer therapies, announced the acceptance of three abstracts for presentation at the 2025 American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results